PhosPrint is funded by the European Innovation Council Accelerator
螒 great success for the spin-off of of NTUA: it is one among 75 selected for funding in the most recent applications from new wave of deep tech start-ups.
PhosPrint is the first Greek company selected by the EIC Accelerator scheme and will translate their research results on the Laser bioprinting device and in vivo applications into pre-clinical and clinics trials.
My warmest congratulations to the co-founder , Professor in the NTUA School of Applied Mathematical and Physical Sciences, and her team.
Andreas G. Boudouvis
NTUA Rector